Skip to main content
Clinical Trials/CTRI/2014/09/005055
CTRI/2014/09/005055
Completed
Phase 4

Prospective, Multi-centre Outcomes Study of Persona® Knee System in Total Knee Arthroplasty

Zimmer India Private Ltd0 sites344 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: M170- Bilateral primary osteoarthritis of kneeHealth Condition 2: null- Patients who require primary Total Knee Arthroplasty using the Persona fixed bearing knee system.Health Condition 3: M171- Unilateral primary osteoarthritisof knee
Sponsor
Zimmer India Private Ltd
Enrollment
344
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Pms

Investigators

Sponsor
Zimmer India Private Ltd

Eligibility Criteria

Inclusion Criteria

  • A patient must meet the following criteria to be eligible for participation:
  • 1\. Age 18 to 80 years old, inclusive.
  • 2\. Qualifies for a primary TKA based on physical exam and medical history, including diagnosis of severe knee pain and disability due to at least one of the following:
  • a) Rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis.
  • b) Collagen disorders and/or avascular necrosis of the femoral condyle.
  • c) Post\-traumatic loss of joint configuration, particularly when there is patellofemoral erosion, dysfunction or prior patellectomy.
  • d) Moderate valgus, varus, or flexion deformities.
  • e) The salvage of previously failed surgical attempts that did not include partial or total knee arthroplasty of the ipsilateral knee.
  • 3\. Participated in a study\-related informed consent process.
  • 4\. Willing and able to provide written informed consent by signing and dating the IRB/EC approved informed consent form.

Exclusion Criteria

  • A patient must not meet the following criteria to be eligible for participation:
  • 1\. Currently participating in any other surgical intervention studies or pain management studies
  • 2\. Previous history of infection in the affected joint and/or other local/systemic infection that may affect the prosthetic joint.
  • 3\. Insufficient bone stock on femoral or tibial surfaces.
  • 4\. Skeletal immaturity.
  • 5\. Neuropathic arthropathy.
  • 6\. Any loss of musculature or neuromuscular disease that compromises the affected limb.
  • 7\. Stable, painless arthrodesis in a satisfactory functional position.
  • 8\. Severe instability secondary to the absence of collateral ligament integrity.
  • 9\. Rheumatoid arthritis accompanied by an ulcer of the skin or a history of recurrent breakdown of the skin.

Outcomes

Primary Outcomes

Not specified

Similar Trials